Coronavirus Disease 2019 Vaccine-Breakthrough Infections Requiring Hospitalization in Mayo Clinic Florida Through August 2021-Reference-Cited by-同舟云学术

Coronavirus Disease 2019 Vaccine-Breakthrough Infections Requiring Hospitalization in Mayo Clinic Florida Through August 2021

Published:2021-11-02 Issue: Volume: Page:
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Bosch Wendelyn¹,Cowart Jennifer B²,Bhakta Shivang³^ORCID,Carter Rickey E⁴,Wadei Hani M⁵,Shah Sadia Z⁶,Sanghavi Devang K³,Pollock Benjamin D⁷,Neville Matthew R⁷,Oman Sven P²,Speicher Leigh⁸,Scindia Ameya D³,Matson Mark W⁹,Moreno Franco Pablo³⁶⁷

Affiliation:

1. Division of Infectious Diseases, Mayo Clinic, Jacksonville, Florida, USA

2. Division of Hospital Internal Medicine, Mayo Clinic, Jacksonville, Florida, USA

3. Department of Critical Care Medicine, Mayo Clinic, Jacksonville, Florida, USA

4. Department of Quantitative Health Sciences, Mayo Clinic, Jacksonville, Florida, USA

5. Division of Nephrology, Mayo Clinic, Jacksonville, Florida, USA

6. Department of Transplantation, Mayo Clinic, Jacksonville, Florida, USA

7. Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Jacksonville, Florida, USA

8. Division of General Internal Medicine, Mayo Clinic, Jacksonville, Florida, USAand

9. Center for Digital Health, Data and Analytics, Mayo Clinic, Rochester, Minnesota, USA

Abstract

Abstract We characterized coronavirus disease 2019 (COVID-19) breakthrough cases admitted to a single center in Florida. With the emergence of delta variant, an increased number of hospitalizations was seen due to breakthrough infections. These patients were older and more likely to have comorbidities. Preventive measures should be maintained even after vaccination.

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

https://academic.oup.com/cid/advance-article-pdf/doi/10.1093/cid/ciab932/41390019/ciab932.pdf

Reference12 articles.

1. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.;Haas;Lancet,2021

2. Effectiveness of Pfizer-BioNTech and Moderna vaccines against COVID-19 among hospitalized adults aged ≥65 years - United States, January–March 2021.;Tenforde;MMWR Morb Mortal Wkly Rep,2021

3. Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study.;Monin;Lancet Oncol,2021

4. Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus: not alarming, but should be taken gravely.;Grupper;Am J Transplant,2021

5. Oropharyngeal shedding of herpesviruses before and after BNT162b2 mRNA vaccination against COVID-19.;Brosh-Nissimov;Vaccine,2021

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Epidemiology, clinical features and outcomes of hospitalized patients with COVID-19 by vaccination status: a multicenter historical cohort study;Virology Journal;2024-03-21

2. Epidemiology, Clinical Features and Outcomes of Hospitalized Patients with COVID-19 by Vaccination status: A Multicenter Historical Cohort Study;2023-12-13

3. Clinical Features and Outcomes of Hospitalized Adult Patients With Breakthrough COVID-19 Infections: A Propensity-Score–Matched Observational Study;American Journal of Epidemiology;2023-10-11

4. Profile and Outcomes of Hospitalized COVID-19 Patients during the Prevalence of the Omicron Variant According to the Brazilian Regions: A Retrospective Cohort Study from 2022;Vaccines;2023-10-05

5. Upregulated CD8+ MAIT cell differentiation and KLRD1 gene expression after inactivated SARS-CoV-2 vaccination identified by single-cell sequencing;Frontiers in Immunology;2023-08-15